Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
81.1M
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
91.4M
-
Shares change
-
+758K
-
Total reported value, excl. options
-
$1.23B
-
Value change
-
-$2.45M
-
Put/Call ratio
-
0.6
-
Number of buys
-
90
-
Number of sells
-
-80
-
Price
-
$13.48
Significant Holders of Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (VRDN) as of Q1 2025
216 filings reported holding VRDN - Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share as of Q1 2025.
Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (VRDN) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91.4M shares
.
Largest 10 shareholders include FMR LLC (12.2M shares), BlackRock, Inc. (5.71M shares), Deep Track Capital, LP (5.38M shares), Kynam Capital Management, LP (4.7M shares), VANGUARD GROUP INC (4.56M shares), VR ADVISER, LLC (3.88M shares), COMMODORE CAPITAL LP (3.6M shares), Fairmount Funds Management LLC (3.45M shares), STATE STREET CORP (2.87M shares), and TANG CAPITAL MANAGEMENT LLC (2.79M shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.